01 / START
The feed showsthe after.
We show what happened in the middle.
Start with the research library
02 / YOUR QUESTION
What brought
you here?
Curiosity usually starts with something personal. Choose the question closest to yours.
Choose a lane. The record stays the standard.
03 / RESET THE FRAME
Peptide is
a category.
Not a result.
Different compounds. Different mechanisms. Different levels of evidence. Start by separating the name from the promise.
04 / READ THE LABEL
One name can
hide a lot.
Identity. Sequence. Form. Source. Study type. A trending label is not a complete record.
- 01 Identity
- 02 Evidence
- 03 Limits
05 / A BETTER FILTER
Three questions
before the hype.
- 01What is it?Identity before associations.
- 02What has been studied?Sources before summaries.
- 03What does the evidence not show?Limits before conclusions.
06 / EVIDENCE STANDARD
Every claim
gets a grade.
Every compound receives an A–U evidence grade. Each grade links to its sources and states what the record does—and does not—establish.
See how evidence is graded
07 / YOUR NEXT MOVE
You saw the after.
Start with the record.
Your curiosity does not need another promise. It needs a place to compare what is known, what is early, and what remains unknown.
- Materials
- 19
- Compounds
- 154
- Sources
- 323
01 / WHAT THIS IS
A library with
a catalog attached.
Most suppliers put a photograph next to a price. We publish the record first — what a compound is, what has actually been studied, and what that evidence does not show.
01 / CATALOG
Everything is visible
No login, no gate, no approval step to look. 9 catalog products across 6 research families, with 19 dose and supply options linked to reference entries.
Browse catalog02 / LIBRARY
Evidence, graded
154 compound entries with identity, storage, source status and an explicit statement of limits. Graded A through U.
Open library03 / ORDERING
By request
There is no checkout on this site. You build a request list, we return written terms, and payment happens against that.
How ordering works02 / RESEARCH FAMILIES
Read it like
a lab record.
Materials are grouped by what they act on, not by what anyone claims they do.
- 01RM-METMetabolic and incretin signallingMaterials studied in metabolic and incretin-receptor pathways. Grouped by molecular target and evidence state, not by outcome.Materials13OriginDeclared by lotUseNon-clinical
- 02RM-GHAGrowth-hormone-axis signallingReleasing-hormone analogs and secretagogues, separated by exact sequence, salt and modification. Related-compound evidence never substitutes for an identity record.Materials1OriginDeclared by lotUseNon-clinical
- 03RM-TRSTissue, repair and matrix signallingPeptides, fragments and blends indexed for cell, matrix and inflammatory-signalling research. Component papers are not presented as blend validation.Materials1OriginDeclared by lotUseNon-clinical
- 04RM-MCEMitochondrial and cellular-energy researchMaterials grouped by mitochondrial signalling, redox chemistry and cellular-energy pathways.Materials1OriginDeclared by lotUseNon-clinical
- 05RM-NBSNeurobehavioural and neuroendocrine signallingA research index for neuroendocrine and signalling targets. Cognitive, mood, sleep and social-outcome language stays outside the catalog.Materials0OriginDeclared by lotUseNon-clinical
- 06RM-MCSMelanocortin signallingMelanocortin-pathway materials kept separate from the indications, dosage forms, routes and controls of any approved comparator.Materials0OriginDeclared by lotUseNon-clinical
- 07RM-ENDEndocrine and peptide-hormone analogsPeptide analogs indexed by endocrine target and exact molecular identity. Approved finished products are comparators, not evidence for separately sourced material.Materials0OriginDeclared by lotUseNon-clinical
- 08RM-BLDDocumented blendsMulti-compound or named formulations in the current catalog. Exact composition remains lot- and product-record specific.Materials2OriginDeclared by lotUseNon-clinical
- 09RM-CVSCoagulation and vascular signallingPeptides and analogs indexed by vasoactive, bradykinin or coagulation target. Approved finished products remain formulation-specific comparators, not supplier or lot validation.Materials0OriginDeclared by lotUseNon-clinical
- 10RM-IMMImmune and host-defense signalingEndogenous and synthetic peptides studied in immune signaling, host defense and inflammatory pathways. Antimicrobial activity in a model does not establish clinical utility or finished-product performance.Materials0OriginDeclared by lotUseNon-clinical
- 11RM-DIADiagnostic and conjugated peptide agentsPeptide-receptor ligands carrying chelators, radionuclides or other functional payloads. The complete conjugate, isotope, activity, formulation and finished-product record matter; an unmodified peptide is not an equivalent substitute.Materials0OriginDeclared by lotUseNon-clinical
- 12RM-PREResearch preparation materialsPreparation materials evaluated as independent products with their own manufacturer, composition, container and lot records.Materials0OriginDeclared by lotUseNon-clinical
- 13RM-NUTNutrients and complex formulationsVitamins, cofactors and named multi-component preparations that require composition-specific source review.Materials1OriginDeclared by lotUseNon-clinical
03 / REFERENCE
A badge is not
a document.
Nothing here is called tested or verified without a record behind it. Every entry states what the evidence shows and, just as plainly, what it does not.
RM-IMMEvidence grade B: Human evidence
Thymosin alpha 1
A 28-amino-acid thymic peptide studied as an immune-modulating research target and in multiple human clinical settings outside a U.S.-approved finished-product pathway.
Read entry →RM-METEvidence grade A: Approved comparator exists
Tirzepatide
A dual GIP/GLP-1 receptor agonist peptide. The active ingredient appears in an FDA-approved product, which establishes that the molecule is well characterised — it says nothing about any individual third-party vial.
Read entry →RM-CVSEvidence grade A: Approved comparator exists
Vasopressin
A cyclic nonapeptide hormone represented by FDA-labeled intravenous finished products.
Read entry →RM-CVSEvidence grade A: Approved comparator exists
Icatibant
A synthetic decapeptide bradykinin B2 receptor antagonist used in FDA-labeled prefilled injection products.
Read entry →RM-IMMEvidence grade B: Human evidence
LL-37
The 37-amino-acid human cathelicidin host-defense peptide, studied across antimicrobial, inflammatory and wound biology with limited human interventional work.
Read entry →RM-METEvidence grade A: Approved comparator exists
Semaglutide
A GLP-1 receptor agonist peptide used in FDA-approved products. Extensively studied as a finished pharmaceutical; that literature describes the approved presentation.
Read entry →04 / ORDERING
Request,
then terms.
No cart, no checkout, no card fields anywhere on this site.
Build a request list
Add the materials you need. Nothing is charged and nothing is reserved.
Send the request
Tell us your organisation, intended research use, quantities and fulfillment preference.
Receive written terms
Availability, lot, origin and price come back in writing before anything is paid.